The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kunel’skaya N.L.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia, 117997;
L.I. Sverzhevsky Moscow Research and Practical Centre of Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152

Baybakova E.V.

GBUZ "Moskovskiĭ nauchno-prakticheskiĭ tsentr otorinolaringologii im. L.I. Sverzhevskogo", Moskva

Yanyushkina E.S.

L.I. Sverzhevsky Research and Clinical Institute of Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152

Chugunova M.A.

GBUZ "Moskovskiĭ nauchno-prakticheskiĭ tsentr otorinolaringologii im. L.I. Sverzhevskogo", Moskva

Tardov M.V.

GBUZ "Moskovskiĭ nauchno-prakticheskiĭ tsentr otorinolaringologii im. L.I. Sverzhevskogo" Departamenta zdravookhraneniia Moskvy

Zaoeva Z.O.

GBUZ "Moskovskiĭ nauchno-prakticheskiĭ tsentr otorinolaringologii im. L.I. Sverzhevskogo", Moskva

Izotova G.N.

Moskovskiĭ nauchno-prakticheskiĭ tsentr otorinolaringologii im. L.I. Sverzhevskogo Departamenta zdravookhraneniia, Moskva, Rossiia, 117152

Larionova E.V.

L.I. Sverzhevskiy Research Institute of Clinical Otorhinolaryngology, Moscow Health Department, Moscow, Russia, 117152

The use of Gliathiline in patients with sensorineural hearing loss

Authors:

Kunel’skaya N.L., Baybakova E.V., Yanyushkina E.S., Chugunova M.A., Tardov M.V., Zaoeva Z.O., Izotova G.N., Larionova E.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2019;84(6): 132‑136

Views: 16370

Downloaded: 232


To cite this article:

Kunel’skaya NL, Baybakova EV, Yanyushkina ES, et al. . The use of Gliathiline in patients with sensorineural hearing loss. Russian Bulletin of Otorhinolaryngology. 2019;84(6):132‑136. (In Russ.)
https://doi.org/10.17116/otorino201984061132

Recommended articles:
Cochleovestibular mani­festations in coro­navirus infe­ction. Russian Bulletin of Otorhinolaryngology. 2024;(3):18-23
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.